MoneyWorks4Me

Sharon Bio-Medicine - Quaterly Results

07 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 443.53 millions against Rs. 452.35 millions recorded during the year-ago period.A slender decline of -11.86% was recorded to Rs. 40.22  millions from Rs. 45.63 millions in the corresponding previous quarter.Operating profit for the quarter ended December 2021 decreased to 69.02 millions as compared to 75.25 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 443.53 452.35 -1.95 1386.19 1242.92 11.53 1728.62 1712.16 0.96
Other Income 5.57 10.12 -44.96 16.85 20.28 -16.91 41.05 17.85 129.97
PBIDT 69.02 75.25 -8.28 215.07 171.98 25.06 257.34 281.96 -8.73
Interest 0.26 0.48 -45.83 0.87 1.36 -36.03 1.75 2.31 -24.24
PBDT 68.76 74.77 -8.04 214.20 170.62 25.54 255.59 -454.08 -156.29
Depreciation 28.54 29.14 -2.06 84.25 86.27 -2.34 115.12 110.59 4.10
PBT 40.22 45.63 -11.86 129.95 84.35 54.06 140.47 -564.67 -124.88
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 40.22 45.63 -11.86 129.95 84.35 54.06 140.47 -564.67 -124.88
Equity 11.51 11.51 0.00 11.51 237.87 -95.16 11.51 237.87 -95.16
PBIDTM(%) 15.56 16.64 -6.45 15.52 13.84 12.13 14.89 16.47 -9.60
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..